Bokf, Na Eli Lilly & CO Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Eli Lilly & CO stock. As of the latest transaction made, Bokf, Na holds 58,133 shares of LLY stock, worth $46.3 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

58,133

Previous 56,578 2.75%

Holding current value

$46.3 Million

Previous $51.2 Million 0.54%

% of portfolio

0.91%

Previous 0.93%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $1.2 Million - $1.49 Million	1,555 Added 2.75%	58,133 $51.5 Million
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $362,435 - $454,520	-500 Reduced 0.88%	56,578 $51.2 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $226,220 - $302,650	-382 Reduced 0.66%	57,078 $44.4 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.3 Million - $1.53 Million	-2,475 Reduced 4.13%	57,460 $33.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $494,253 - $681,404	-1,137 Reduced 1.86%	59,935 $32.2 Million
Q2 2023 Aug 21, 2023	SELL	$350.74 - $468.98 $1.26 Million - $1.69 Million	-3,601 Reduced 5.57%	61,072 $28.6 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $1.16 Million - $1.37 Million	-3,747 Reduced 5.48%	64,673 $22.2 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $980,084 - $1.14 Million	-3,048 Reduced 4.26%	68,420 $25 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $6.33 Million - $7.22 Million	21,362 Added 42.63%	71,468 $23.1 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $10,313 - $12,108	-37 Reduced 0.07%	50,106 $16.2 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $931,249 - $1.16 Million	-3,968 Reduced 7.33%	50,143 $14.4 Million
Q4 2021 Mar 11, 2022	SELL	$224.85 - $279.04 $487,025 - $604,400	-2,166 Reduced 3.85%	54,111 $14.9 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $4.46 Million - $5.49 Million	-20,147 Reduced 26.36%	56,277 $13 Million
Q1 2021 Apr 21, 2021	BUY	$164.32 - $212.72 $626,223 - $810,675	3,811 Added 5.25%	76,424 $14.3 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $70,187 - $92,874	-538 Reduced 0.74%	72,613 $12.3 Million
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $3.43 Million - $3.96 Million	23,425 Added 47.11%	73,151 $10.8 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $1.11 Million - $1.33 Million	8,112 Added 19.49%	49,726 $8.16 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $716,919 - $887,341	6,022 Added 16.92%	41,614 $5.77 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $789,924 - $978,392	-7,388 Reduced 17.19%	35,592 $4.68 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $1.27 Million - $1.38 Million	-11,862 Reduced 21.63%	42,980 $4.81 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $2.74 Million - $3.2 Million	-24,735 Reduced 31.08%	54,842 $6.08 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $215,162 - $253,261	1,933 Added 2.49%	79,577 $10.3 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $444,144 - $497,576	-4,194 Reduced 5.12%	77,644 $8.99 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $958,197 - $1.2 Million	-11,160 Reduced 12.0%	81,838 $8.78 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $1,362 - $1,563	18 Added 0.02%	92,998 $7.94 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $172,760 - $203,932	2,328 Added 2.57%	92,980 $7.19 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $205,915 - $220,867	2,513 Added 2.85%	90,652 $7.66 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $835,670 - $927,510	10,843 Added 14.03%	88,139 $7.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	77,296	77,296 $6.36 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account